GILDER GAGNON HOWE & CO LLC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 69 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$255,219
+8.2%
160,515
-0.6%
0.00%0.0%
Q4 2022$235,800
-65.8%
161,507
-0.1%
0.00%
-66.7%
Q3 2022$690,000
+9.4%
161,607
-0.6%
0.01%
+9.1%
Q2 2022$631,000
-27.3%
162,547
-10.9%
0.01%
+37.5%
Q1 2022$868,000
+10.9%
182,396
-15.0%
0.01%
+100.0%
Q4 2021$783,000
-35.5%
214,566
+41.8%
0.00%
-33.3%
Q3 2021$1,214,000
-29.0%
151,350
+0.3%
0.01%
-25.0%
Q2 2021$1,711,000150,8740.01%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$717,2970.22%
Aisling Capital Management LP 288,571$300,1140.12%
BVF INC/IL 3,614,662$3,759,2480.10%
TRUST CO OF TOLEDO NA /OH/ 33,213$34,5420.01%
MAI Capital Management 397,670$413,5770.01%
Laurion Capital Management LP 698,000$725,9200.00%
RP Management, LLC 3,700$3,8480.00%
UNITED BANK 20,000$20,8000.00%
BOURGEON CAPITAL MANAGEMENT LLC 7,500$7,8000.00%
XTX Topco Ltd 12,084$12,5670.00%
View complete list of VIRACTA THERAPEUTICS INC shareholders